On the public citation graph
A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee
0 signed · 261 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1522-2594(199905)41:5<857::aid-mrm1>3.0.co;2-eopenalex-snapshot
Nondestructive imaging of human cartilage glycosaminoglycan concentration by MRI
inferredcites →https://doi.org/10.1002/1529-0131(199910)42:10<2094::aid-anr9>3.0.co;2-yopenalex-snapshot
Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1? in rats
inferredcites →https://doi.org/10.1002/1529-0131(200109)44:9<2078::aid-art358>3.0.co;2-jopenalex-snapshot
Interleukin-1, tumor necrosis factor ?, and interleukin-17 synergistically up-regulate nitric oxide and prostaglandin E2 production in explants of human osteoarthritic knee menisci
inferredcites →https://doi.org/10.1002/art.1780290816openalex-snapshot
Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the knee
inferredcites →https://doi.org/10.1002/art.1780390914openalex-snapshot
Chondroprotective effect of intraarticular injections of interleukin‐1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase‐1 expression
inferredcites →https://doi.org/10.1002/art.1780400604openalex-snapshot
In vivo suppression of early experimental osteoarthritis by interleukin‐1 receptor antagonist using gene therapy
inferredcites →https://doi.org/10.1002/art.24096openalex-snapshot
Intraarticular injection of anakinra in osteoarthritis of the knee: A multicenter, randomized, double‐blind, placebo‐controlled study
inferredcites →https://doi.org/10.1016/j.brainresrev.2008.12.020openalex-snapshot
Role of interleukin-1β during pain and inflammation
inferredcites →https://doi.org/10.1016/j.joca.2004.12.004openalex-snapshot
Inhibition of adenosine kinase attenuates interleukin-1- and lipopolysaccharide-induced alterations in articular cartilage metabolism
inferredcites →https://doi.org/10.1016/j.joca.2007.07.008openalex-snapshot
Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial
inferredcites →https://doi.org/10.1016/s0002-9440(10)65368-0openalex-snapshot
In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee Joints
inferredcites →https://doi.org/10.1016/s0889-857x(21)00331-8openalex-snapshot
CYTOKINES AND INFLAMMATION IN CARTILAGE DEGRADATION
inferredcites →https://doi.org/10.1038/sj.gt.3301608openalex-snapshot
Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene
inferredcites →https://doi.org/10.1074/jbc.275.5.3687openalex-snapshot
Potent Inhibition of the Master Chondrogenic FactorSox9 Gene by Interleukin-1 and Tumor Necrosis Factor-α
inferredcites →https://doi.org/10.1080/03009740310000355openalex-snapshot
Regulation of nitric oxide production in osteoarthritic and rheumatoid cartilageRole of endogenous IL‐1 inhibitors
inferredcites →https://doi.org/10.1177/0006355x2002039001002025openalex-snapshot
The role of cytokines in osteoarthritis pathophysiology
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4796592openalex-extracted
Treatment with Anti-Tnfα Antibodies Increases Gags Levels and Reduces the Activity of Mmp-2 and Mmp-9 in Synovial Fluid of Horses with Osteoarthritis
inferred← citeshttps://doi.org/10.1002/9783527682423.ch31openalex-snapshot
MAbs Targeting Soluble Mediators in Phase 1 and 2 Clinical Studies Immunological Disorders
inferred← citeshttps://doi.org/10.1002/advs.202205161openalex-snapshot
Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis by Non‐Amplification of Activin A‐ACVR2B‐NOX4 Axis Pathway
inferred← citeshttps://doi.org/10.1002/arj.70021openalex-snapshot
Amniotic Suspension Allograft and Bone Marrow Aspirate Concentrate Results in Highly Variable Proinflammatory Cytokines in a Coculture Model of Osteoarthritis
inferred← citeshttps://doi.org/10.1002/art.34453openalex-snapshot
Osteoarthritis: A disease of the joint as an organ
inferred← citeshttps://doi.org/10.1002/art.40840openalex-snapshot
A Phase II Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
inferred← citeshttps://doi.org/10.1002/art.41158openalex-snapshot
Regulation of the Inflammatory Synovial Fibroblast Phenotype by Metastasis‐Associated Lung Adenocarcinoma Transcript 1 Long Noncoding RNA in Obese Patients With Osteoarthritis
inferred← citeshttps://doi.org/10.1002/art.42649openalex-snapshot
Relation of Intra‐Articular Mineralization to Knee Pain in Knee Osteoarthritis: A Longitudinal Analysis in the MOST Study
inferred← citeshttps://doi.org/10.1002/art.42832openalex-snapshot
Intra‐Articular Mineralization on Computerized Tomography of the Knee and Risk of Cartilage Damage: The Multicenter Osteoarthritis Study
inferred← citeshttps://doi.org/10.1002/btm2.10298openalex-snapshot
Intra‐articular injection of rapamycin microparticles prevent senescence and effectively treat osteoarthritis
inferred← citeshttps://doi.org/10.1002/exp.20220132openalex-snapshot
The potential role of synovial cells in the progression and treatment of osteoarthritis
inferred← citeshttps://doi.org/10.1002/jor.22963openalex-snapshot
Characterization of neopeptides in equine articular cartilage degradation
inferred← citeshttps://doi.org/10.1002/jor.23756openalex-snapshot
Novel protein therapeutic joint retention strategy based on collagen‐binding Avimers
inferred← citeshttps://doi.org/10.1002/jsp2.70095openalex-snapshot
Plasma Pro‐ and Anti‐Inflammatory Cytokines in an Observational Chronic Low Back Pain Cohort
inferred← citeshttps://doi.org/10.1002/term.3031openalex-snapshot
Resveratrol counteracts IL‐1β‐mediated impairment of extracellular matrix deposition in 3D articular chondrocyte constructs
inferred← citeshttps://doi.org/10.1007/978-1-4614-6819-6_2openalex-snapshot
Inflammasomes and Obesity
inferred← citeshttps://doi.org/10.1007/978-3-030-33358-4_8openalex-snapshot
Non-Surgical Management of Pre-Arthritic Dysplastic Hip Pain
inferred← citeshttps://doi.org/10.1007/978-3-030-79485-9_12openalex-snapshot
Monocytes, Macrophages and Joint Inflammation in Osteoarthritis
inferred← citeshttps://doi.org/10.1007/978-3-031-55653-1_4openalex-snapshot
Drug Delivery Systems for Intervertebral Disc
inferred← citeshttps://doi.org/10.1007/978-3-319-19560-5_10openalex-snapshot
Drug/Agent Treatments for Osteoarthritis: Present and Future
inferred← citeshttps://doi.org/10.1007/978-3-319-19560-5_11openalex-snapshot
Safety Profile of Current OA Therapies: Evidence from Clinical Trials
inferred← citeshttps://doi.org/10.1007/978-3-319-28100-1_32-1openalex-snapshot
Arthritic Conditions Affecting the Temporomandibular Joint
inferred← citeshttps://doi.org/10.1007/978-3-319-28100-1_32-2openalex-snapshot
Arthritic Conditions Affecting the Temporomandibular Joint
inferred← citeshttps://doi.org/10.1007/978-3-319-45803-8_5openalex-snapshot
Pro- and Anti-inflammatory Cytokine Profiles in Osteoarthritis
inferred← citeshttps://doi.org/10.1007/978-3-319-72303-7_32openalex-snapshot
Arthritic Conditions Affecting the Temporomandibular Joint
inferred← citeshttps://doi.org/10.1007/978-3-319-98605-0_39openalex-snapshot
Interleukin-1 Mediated Autoinflammation from Heart Disease to Cancer
inferred← citeshttps://doi.org/10.1007/978-981-16-7200-2_15openalex-snapshot
Biologics in Osteoarthritis
inferred← citeshttps://doi.org/10.1007/s00726-015-2168-xopenalex-snapshot
Alterations of amino acid metabolism in osteoarthritis: its implications for nutrition and health
inferred← citeshttps://doi.org/10.1007/s10067-022-06073-7openalex-snapshot
Erosive Hand OsteoArthritis (EHOA): analysis of consecutive patients presenting with EHOA in a hospital-based rheumatology practice and its implications for an upcoming interventional study
inferred← citeshttps://doi.org/10.1007/s10067-024-07042-yopenalex-snapshot
Inflammation as a therapeutic target for osteoarthritis: A literature review of clinical trials
inferred← citeshttps://doi.org/10.1007/s11094-022-02572-8openalex-snapshot
New Directions in the Development of Pharmacotherapy for Osteoarthrosis Based on Modern Concepts of the Disease Pathogenesis (A Review)
inferred← citeshttps://doi.org/10.1007/s11914-022-00729-8openalex-snapshot
Inflammasomes and the IL-1 Family in Bone Homeostasis and Disease
inferred← citeshttps://doi.org/10.1007/s12088-022-01027-8openalex-snapshot
Construction of A375·S2 Melanoma Cell Line with High Sensibility to IL-1 by Overexpressing IL-1 Receptor
inferred← citeshttps://doi.org/10.1007/s13311-020-00937-zopenalex-snapshot
Novel Analgesics with Peripheral Targets
inferred← citeshttps://doi.org/10.1007/s40122-024-00603-8openalex-snapshot
Tumor Necrosis Factor and Interleukin Modulators for Pathologic Pain States: A Narrative Review
inferred← citeshttps://doi.org/10.1007/s40674-023-00203-1openalex-snapshot
Intra-articular Mineralization and Association with Osteoarthritis Development and Outcomes
inferred← citeshttps://doi.org/10.1007/s40883-025-00518-6openalex-snapshot
Cationic Dendrimer Nanoformulation Improves Therapeutic Efficacy of Pro-Anabolic and Anti-Catabolic Therapeutics in Osteoarthritis
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.11193-6openalex-snapshot
Regulation of the Inflammatory Process in Osteoarthritis
inferred← citeshttps://doi.org/10.1016/b978-0-12-803302-9.00008-7openalex-snapshot
Modulating Inflammatory Cytokines
inferred← citeshttps://doi.org/10.1016/b978-0-12-822514-1.00010-9openalex-snapshot
A framework for addressing senescent cell burden in the osteoarthritic knee
inferred← citeshttps://doi.org/10.1016/b978-0-323-09138-1.00061-9openalex-snapshot
Cytokine neutralizers
inferred← citeshttps://doi.org/10.1016/b978-0-323-90250-2.00006-6openalex-snapshot
Immunogenetic markers as prognostic tools for the management of various human diseases
inferred← citeshttps://doi.org/10.1016/b978-0-323-91802-2.00010-4openalex-snapshot
Therapeutic targeting of inflammasome signaling by blocking interleukin-1
inferred← citeshttps://doi.org/10.1016/j.actbio.2018.12.004openalex-snapshot
Cartilage penetrating cationic peptide carriers for applications in drug delivery to avascular negatively charged tissues
inferred← citeshttps://doi.org/10.1016/j.actbio.2019.04.051openalex-snapshot
Injectable biomaterials for delivery of interleukin-1 receptor antagonist: Toward improving its therapeutic effect
inferred← citeshttps://doi.org/10.1016/j.amsu.2021.103077openalex-snapshot
An up to date on clinical prospects and management of osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.arr.2021.101413openalex-snapshot
Cellular senescence in knee osteoarthritis: molecular mechanisms and therapeutic implications
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102785openalex-snapshot
The revisited role of interleukin-1 alpha and beta in autoimmune and inflammatory disorders and in comorbidities
inferred← citeshttps://doi.org/10.1016/j.bcp.2019.02.034openalex-snapshot
Emerging therapeutic agents in osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.berh.2022.101810openalex-snapshot
Osteoarthritis today: Lost in translation?
inferred← citeshttps://doi.org/10.1016/j.berh.2023.101841openalex-snapshot
What is new in pharmacological treatment for osteoarthritis?
inferred← citeshttps://doi.org/10.1016/j.berh.2025.102102openalex-snapshot
What's new in osteoarthritis?
inferred← citeshttps://doi.org/10.1016/j.bone.2012.02.012openalex-snapshot
The role of synovitis in osteoarthritis pathogenesis
inferred← citeshttps://doi.org/10.1016/j.bonr.2023.101658openalex-snapshot
Post-traumatic osteoarthritis: A review of pathogenic mechanisms and novel targets for mitigation
inferred← citeshttps://doi.org/10.1016/j.cellsig.2018.10.005openalex-snapshot
Interleukin-1β signaling in osteoarthritis – chondrocytes in focus
inferred← citeshttps://doi.org/10.1016/j.cytogfr.2026.101532openalex-snapshot
Spatiotemporal heterogeneity of immune cells in knee osteoarthritis: Cytokine actions and targeted therapies
inferred← citeshttps://doi.org/10.1016/j.drudis.2024.104187openalex-snapshot
Unveiling the macrophage dynamics in osteoarthritic joints: From inflammation to therapeutic strategies
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2023.128453openalex-snapshot
CircIRAK3 exerts negative feedback regulation on inflammation by binding to HNRNP U and destabilizing proinflammatory cytokine mRNA in osteoarthritis and chondrogenesis
inferred← citeshttps://doi.org/10.1016/j.intimp.2026.116709openalex-snapshot
Comment on “Bergapten ameliorates osteoarthritis progression by inhibiting the PI3K/AKT/mTOR pathway to activate mitophagy and suppress pyroptosis”
inferred← citeshttps://doi.org/10.1016/j.jare.2024.06.010openalex-snapshot
Pyroptosis: A spoiler of peaceful coexistence between cells in degenerative bone and joint diseases
inferred← citeshttps://doi.org/10.1016/j.jconrel.2013.10.010openalex-snapshot
Pharmacokinetics, biocompatibility and bioavailability of a controlled release monoclonal antibody formulation
inferred← citeshttps://doi.org/10.1016/j.jconrel.2020.08.041openalex-snapshot
Drug delivery in intervertebral disc degeneration and osteoarthritis: Selecting the optimal platform for the delivery of disease-modifying agents
inferred← citeshttps://doi.org/10.1016/j.jddst.2024.106264openalex-snapshot
Unlocking the future of osteoarthritis: Material engineering and drug delivery confluence for advanced therapeutic approaches
inferred← citeshttps://doi.org/10.1016/j.jevs.2025.105384openalex-snapshot
Early effects of anti-TNFα antibodies in horses with osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2014.03.004openalex-snapshot
The hallmarks of osteoarthritis and the potential to develop personalised disease-modifying pharmacological therapeutics
inferred← citeshttps://doi.org/10.1016/j.joca.2014.10.002openalex-snapshot
Metabolic triggered inflammation in osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2015.03.027openalex-snapshot
Human genome-wide expression analysis reorients the study of inflammatory mediators and biomechanics in osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2015.07.004openalex-snapshot
Mesenchymal stem cells for the management of inflammation in osteoarthritis: state of the art and perspectives
inferred← citeshttps://doi.org/10.1016/j.joca.2016.07.017openalex-snapshot
Disease-modifying treatments for osteoarthritis (DMOADs) of the knee and hip: lessons learned from failures and opportunities for the future
inferred← citeshttps://doi.org/10.1016/j.joca.2016.09.009openalex-snapshot
Interleukin-1 is not involved in synovial inflammation and cartilage destruction in collagenase-induced osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2017.01.002openalex-snapshot
Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA
inferred← citeshttps://doi.org/10.1016/j.joca.2017.09.007openalex-snapshot
Safety, tolerability, and pharmacodynamics of an anti-interleukin-1α/β dual variable domain immunoglobulin in patients with osteoarthritis of the knee: a randomized phase 1 study
inferred← citeshttps://doi.org/10.1016/j.joca.2018.10.007openalex-snapshot
Regional gene expression analysis of multiple tissues in an experimental animal model of post-traumatic osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2018.12.012openalex-snapshot
Molecular expression patterns in the synovium and their association with advanced symptomatic knee osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.joca.2020.01.012openalex-snapshot
Targeting GM-CSF for collagenase-induced osteoarthritis pain and disease in mice
inferred← citeshttps://doi.org/10.1016/j.joca.2021.04.009openalex-snapshot
The E3 ubiquitin ligase Itch limits the progression of post-traumatic osteoarthritis in mice by inhibiting macrophage polarization
inferred← citeshttps://doi.org/10.1016/j.joca.2021.07.005openalex-snapshot
A single dose of anti-IL-1β antibodies prevents Western diet-induced immune activation during early stage collagenase-induced osteoarthritis, but does not ameliorate end-stage pathology
inferred← citeshttps://doi.org/10.1016/j.joca.2021.09.003openalex-snapshot
Cannabinoid receptor type 2 is upregulated in synovium following joint injury and mediates anti-inflammatory effects in synovial fibroblasts and macrophages
inferred← citeshttps://doi.org/10.1016/j.joca.2021.11.009openalex-snapshot
Osteoarthritis year in review 2021: biology
inferred← citeshttps://doi.org/10.1016/j.joca.2022.03.012openalex-snapshot
Advances in organ-on-a-chip systems for modelling joint tissue and osteoarthritic diseases
inferred← citeshttps://doi.org/10.1016/j.joca.2022.09.014openalex-snapshot
IL-1β inhibition combined with cholesterol-lowering therapies decreases synovial lining thickness and spontaneous cartilage degeneration in a humanized dyslipidemia mouse model
inferred← citeshttps://doi.org/10.1016/j.joca.2023.01.573openalex-snapshot
Sustained intra-cartilage delivery of interleukin-1 receptor antagonist using cationic peptide and protein-based carriers
inferred← citeshttps://doi.org/10.1016/j.joca.2023.04.001openalex-snapshot
Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial
inferred← citeshttps://doi.org/10.1016/j.joca.2026.01.002openalex-snapshot
Machine learning based prioritisation of genes associated with osteoarthritis joint damage in animals
inferred← citeshttps://doi.org/10.1016/j.joca.2026.04.017openalex-snapshot
The association of CT-detected intra-articular calcification with MRI-detected effusion-synovitis and Hoffa-synovitis in knee OA: The Multicenter Osteoarthritis study
inferred← citeshttps://doi.org/10.1016/j.jot.2024.08.006openalex-snapshot
Biomarkers for hypertrophic chondrocyte differentiation are associated with spatial cellular organisation and suggest endochondral ossification-like processes in osteoarthritic cartilage: An exploratory study
inferred← citeshttps://doi.org/10.1016/j.jot.2026.101138openalex-snapshot
Dermal fibroblasts attenuate osteoarthritis by restoring synovial fibroblast homeostasis
inferred← citeshttps://doi.org/10.1016/j.medntd.2020.100052openalex-snapshot
Metabolic syndrome and osteoarthritis: Possible mechanisms and management strategies
inferred← citeshttps://doi.org/10.1016/j.ocarto.2021.100209openalex-snapshot
The design of a randomized, placebo-controlled, dose-ranging trial to investigate the efficacy and safety of the ADAMTS-5 inhibitor S201086/GLPG1972 in knee osteoarthritis
inferred← citeshttps://doi.org/10.1016/j.ocarto.2021.100212openalex-snapshot
Challenges and opportunities of pharmacological interventions for osteoarthritis: A review of current clinical trials and developments
inferred← citeshttps://doi.org/10.1016/j.omtn.2025.102552openalex-snapshot
Antibody and aptamer-based therapies for osteoarthritis: Application of antibodies and promise of aptamers
inferred← citeshttps://doi.org/10.1016/j.phrs.2025.107585openalex-snapshot
Do cytokines play a role in the transition from acute to chronic musculoskeletal pain?
inferred← citeshttps://doi.org/10.1016/j.semarthrit.2022.152070openalex-snapshot
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit
inferred← citeshttps://doi.org/10.1016/j.smim.2013.10.008openalex-snapshot
Treating inflammation by blocking interleukin-1 in humans
inferred← citeshttps://doi.org/10.1016/s2665-9913(23)00190-xopenalex-snapshot
Three-dimensional, in-vitro approaches for modelling soft-tissue joint diseases
inferred← citeshttps://doi.org/10.1021/acsami.0c10458openalex-snapshot
Chondrocyte-Targeted MicroRNA Delivery by Engineered Exosomes toward a Cell-Free Osteoarthritis Therapy
inferred← citeshttps://doi.org/10.1038/boneres.2015.40openalex-snapshot
Current research on pharmacologic and regenerative therapies for osteoarthritis
inferred← citeshttps://doi.org/10.1038/nrd3800openalex-snapshot
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
inferred← citeshttps://doi.org/10.1038/nrrheum.2013.44openalex-snapshot
Biologic agents in osteoarthritis: hopes and disappointments
inferred← citeshttps://doi.org/10.1038/nrrheum.2016.136openalex-snapshot
Low-grade inflammation as a key mediator of the pathogenesis of osteoarthritis
inferred← citeshttps://doi.org/10.1038/nrrheum.2016.166openalex-snapshot
Interleukin-1 function and role in rheumatic disease
inferred← citeshttps://doi.org/10.1038/nrrheum.2016.210openalex-snapshot
Cartilage-targeting drug delivery: can electrostatic interactions help?
inferred← citeshttps://doi.org/10.1038/s12276-021-00710-yopenalex-snapshot
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
inferred← citeshttps://doi.org/10.1038/s41392-025-02556-6openalex-snapshot
Osteoarthritis: molecular pathogenesis and potential therapeutic options
inferred← citeshttps://doi.org/10.1038/s41413-026-00549-xopenalex-snapshot
Advances in heterogeneity and classification of osteoarthritis
inferred← citeshttps://doi.org/10.1038/s41419-020-03155-9openalex-snapshot
Targeting miR-18a sensitizes chondrocytes to anticytokine therapy to prevent osteoarthritis progression
inferred← citeshttps://doi.org/10.1038/s41584-019-0185-yopenalex-snapshot
Anti-IL-1 for the treatment of OA: dead or alive?
inferred← citeshttps://doi.org/10.1038/s41584-019-0221-yopenalex-snapshot
Therapeutic options for targeting inflammatory osteoarthritis pain
inferred← citeshttps://doi.org/10.1038/s41584-019-0277-8openalex-snapshot
The IL-1 family of cytokines and receptors in rheumatic diseases
inferred← citeshttps://doi.org/10.1038/s41584-020-00518-6openalex-snapshot
Emerging pharmaceutical therapies for osteoarthritis
inferred← citeshttps://doi.org/10.1038/s41584-022-00749-9openalex-snapshot
Synovial inflammation in osteoarthritis progression
inferred← citeshttps://doi.org/10.1038/s41584-025-01280-3openalex-snapshot
Peripheral neuronal sensitization and neurovascular remodelling in osteoarthritis pain
inferred← citeshttps://doi.org/10.1038/s41584-026-01395-1openalex-snapshot
Advances in targeting IL-1 family cytokines for the treatment of inflammatory diseases
inferred← citeshttps://doi.org/10.1038/s41598-021-86064-xopenalex-snapshot
Serum C-reactive protein metabolite (CRPM) is associated with incidence of contralateral knee osteoarthritis
inferred← citeshttps://doi.org/10.1039/d0bm00596gopenalex-snapshot
Rapamycin–PLGA microparticles prevent senescence, sustain cartilage matrix production under stress and exhibit prolonged retention in mouse joints
inferred← citeshttps://doi.org/10.1055/s-0040-1708540openalex-snapshot
The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis
inferred← citeshttps://doi.org/10.1073/pnas.1116579108openalex-snapshot
Reply to Ea et al.: Hydroxyapatite crystals induce inflammation through the NLRP3 inflammasome in vitro and in vivo
inferred← citeshttps://doi.org/10.1080/03009742.2017.1340511openalex-snapshot
Is synovitis detected on non-contrast-enhanced magnetic resonance imaging associated with serum biomarkers and clinical signs of effusion? Data from the Osteoarthritis Initiative
inferred← citeshttps://doi.org/10.1080/03602532.2019.1687511openalex-snapshot
Systemic drugs with impact on osteoarthritis
inferred← citeshttps://doi.org/10.1080/13543784.2018.1539075openalex-snapshot
Investigational drugs for the treatment of osteoarthritis, an update on recent developments
inferred← citeshttps://doi.org/10.1080/14656566.2020.1732924openalex-snapshot
Pharmacotherapy for knee osteoarthritis: current and emerging therapies
inferred← citeshttps://doi.org/10.1080/14712598.2016.1229774openalex-snapshot
Monoclonal antibodies for the treatment of osteoarthritis
inferred← citeshttps://doi.org/10.1080/14728214.2018.1547706openalex-snapshot
Disease-modifying drugs in osteoarthritis: current understanding and future therapeutics
inferred← citeshttps://doi.org/10.1080/14728214.2022.2125506openalex-snapshot
Emerging injectable therapies for osteoarthritis
inferred← citeshttps://doi.org/10.1080/14728214.2024.2386174openalex-snapshot
A comprehensive review of phase 2/3 trials in osteoarthritis: an expert opinion
inferred← citeshttps://doi.org/10.1080/14728222.2018.1448062openalex-snapshot
Inducible nitric oxide synthase as a target for osteoarthritis treatment
inferred← citeshttps://doi.org/10.1080/17425247.2025.2539963openalex-snapshot
Cell membrane-coated nanoparticles-based drug delivery systems for osteoarthritis therapy: the application and potential translation into clinical therapy
inferred← citeshttps://doi.org/10.1080/19420862.2015.1026501openalex-snapshot
Generation and characterization of ABT-981, a dual variable domain immunoglobulin (DVD-IgTM) molecule that specifically and potently neutralizes both IL-1α and IL-1β
inferred← citeshttps://doi.org/10.1080/19420862.2017.1353853openalex-snapshot
Generation and functional characterization of anti-human and anti-mouse IL-36R antagonist monoclonal antibodies
inferred← citeshttps://doi.org/10.1089/rej.2013.1475openalex-snapshot
Mineralization of the Connective Tissue: A Complex Molecular Process Leading to Age-Related Loss of Function
inferred← citeshttps://doi.org/10.1093/bbb/zbaf119openalex-snapshot
IL-1β restrains its own apoptosis-promoting activity via NF-κB (RelA) Ser276/p62-mediated elimination of damaged mitochondria in chondrocytes
inferred← citeshttps://doi.org/10.1093/rheumatology/keaa910openalex-snapshot
The role of inflammation in mesenchymal stromal cell therapy in osteoarthritis, perspectives for post-traumatic osteoarthritis: a review
inferred← citeshttps://doi.org/10.1093/rheumatology/kev269openalex-snapshot
Treating rheumatological diseases and co-morbidities with interleukin-1 blocking therapies
inferred← citeshttps://doi.org/10.1093/rheumatology/kew278openalex-snapshot
Developing anti-inflammatory therapeutics for patients with osteoarthritis
inferred← citeshttps://doi.org/10.1093/rheumatology/kex496openalex-snapshot
Current status and future prospects for disease modification in osteoarthritis
inferred← citeshttps://doi.org/10.1097/bor.0b013e32835a9381openalex-snapshot
Prognostic biomarkers in osteoarthritis
inferred← citeshttps://doi.org/10.1097/in9.0000000000000031openalex-snapshot
Inflammatory mechanisms in post-traumatic osteoarthritis: a role for CaMKK2
inferred← citeshttps://doi.org/10.1097/j.pain.0000000000002737openalex-snapshot
Proinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain
inferred← citeshttps://doi.org/10.1101/2021.07.20.453073openalex-snapshot
Rapamycin microparticles induce autophagy, prevent senescence and are effective in treatment of Osteoarthritis
inferred← citeshttps://doi.org/10.1111/acel.14092openalex-snapshot
Osteoclasts and osteoarthritis: Novel intervention targets and therapeutic potentials during aging
inferred← citeshttps://doi.org/10.1111/exd.14423openalex-snapshot
Location, location, location: Melanoma cells “living at the edge”
inferred← citeshttps://doi.org/10.1111/jnc.15438openalex-snapshot
Spinal interleukin‐1β induces mechanical spinal hyperexcitability in rats: Interactions and redundancies with TNF and IL‐6
inferred← citeshttps://doi.org/10.1124/jpet.113.205443openalex-snapshot
Detailed Mechanistic Analysis of Gevokizumab, an Allosteric Anti–IL-1β Antibody with Differential Receptor-Modulating Properties
inferred← citeshttps://doi.org/10.1136/annrheumdis-2013-203670openalex-snapshot
AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis
inferred← citeshttps://doi.org/10.1136/annrheumdis-2018-213336openalex-snapshot
Phase IIa, placebo-controlled, randomised study of lutikizumab, an anti-interleukin-1α and anti-interleukin-1β dual variable domain immunoglobulin, in patients with erosive hand osteoarthritis
inferred← citeshttps://doi.org/10.1136/rmdopen-2015-000083openalex-snapshot
OsteoRheumatology: a new discipline?
inferred← citeshttps://doi.org/10.1155/2017/4535326openalex-snapshot
Effect of Acupotomy on FAK‐PI3K Signaling Pathways in KOA Rabbit Articular Cartilages
inferred← citeshttps://doi.org/10.1155/2019/2363460openalex-snapshot
Exploring the Involvement of NLRP3 and IL-1βin Osteoarthritis of the Hand: Results from a Pilot Study
inferred← citeshttps://doi.org/10.1155/2020/9013283openalex-snapshot
Is Lutikizumab, an Anti–Interleukin‐1 α / β Dual Variable Domain Immunoglobulin, efficacious for Osteoarthritis? Results from a bayesian network meta‐analysis
inferred← citeshttps://doi.org/10.1159/000531798openalex-snapshot
Role of the Sympathetic Nervous System in Mild Chronic Inflammatory Diseases: Focus on Osteoarthritis
inferred← citeshttps://doi.org/10.1172/jci95147openalex-snapshot
Senescent cells and osteoarthritis: a painful connection
inferred← citeshttps://doi.org/10.1177/1759720x17704639openalex-snapshot
The potential role of adult stem cells in the management of the rheumatic diseases
inferred← citeshttps://doi.org/10.1177/1759720x221080377openalex-snapshot
Efficacy and safety of biologic agents for the treatment of osteoarthritis: a meta-analysis of randomized placebo-controlled trials
inferred← citeshttps://doi.org/10.1177/1759720x231169839openalex-snapshot
Latest insights in disease-modifying osteoarthritis drugs development
inferred← citeshttps://doi.org/10.1177/2040622312454157openalex-snapshot
Prospects for treating osteoarthritis: enzyme–protein interactions regulating matrix metalloproteinase activity
inferred← citeshttps://doi.org/10.1177/2040622312462734openalex-snapshot
New findings in osteoarthritis pathogenesis: therapeutic implications
inferred← citeshttps://doi.org/10.1183/13993003.00563-2019openalex-snapshot
Current perspectives on the role of interleukin-1 signalling in the pathogenesis of asthma and COPD
inferred← citeshttps://doi.org/10.1186/ar3436openalex-snapshot
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy
inferred← citeshttps://doi.org/10.1186/ar4381openalex-snapshot
Cytokine signaling-1 suppressor is inducible by IL-1beta and inhibits the catabolic effects of IL-1beta in chondrocytes: its implication in the paradoxical joint-protective role of IL-1beta
inferred← citeshttps://doi.org/10.1186/ar4591openalex-snapshot
Targeting pro-inflammatory cytokines following joint injury: acute intra-articular inhibition of interleukin-1 following knee injury prevents post-traumatic arthritis
inferred← citeshttps://doi.org/10.1186/s12891-017-1410-yopenalex-snapshot
Pigment Epithelium-Derived Factor (PEDF) mediates cartilage matrix loss in an age-dependent manner under inflammatory conditions
inferred← citeshttps://doi.org/10.1186/s12931-017-0633-7openalex-snapshot
A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease
inferred← citeshttps://doi.org/10.1186/s12933-026-03187-zopenalex-snapshot
Single-cell insights into maladaptive endothelial plasticity and therapeutic targets in diabetic vascular complications
inferred← citeshttps://doi.org/10.1186/s13018-023-03590-2openalex-snapshot
Efficacy and safety of anti-interleukin-1 therapeutics in the treatment of knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1186/s13287-018-0892-3openalex-snapshot
Melatonin rescued interleukin 1β-impaired chondrogenesis of human mesenchymal stem cells
inferred← citeshttps://doi.org/10.1186/s40634-016-0054-4openalex-snapshot
Intra‐articular interleukin‐1 receptor antagonist (IL1‐ra) microspheres for posttraumatic osteoarthritis: in vitro biological activity and in vivo disease modifying effect
inferred← citeshttps://doi.org/10.1186/s41232-019-0101-5openalex-snapshot
The role of interleukin-1 in general pathology
inferred← citeshttps://doi.org/10.1242/dmm.016881openalex-snapshot
Targets, models and challenges in osteoarthritis research
inferred← citeshttps://doi.org/10.12688/f1000research.18831.1openalex-snapshot
IL-1 in osteoarthritis: time for a critical review of the literature
inferred← citeshttps://doi.org/10.12688/f1000research.22115.1openalex-snapshot
Recent advances in the treatment of osteoarthritis
inferred← citeshttps://doi.org/10.1371/journal.pone.0213734openalex-snapshot
Discerning the spatio-temporal disease patterns of surgically induced OA mouse models
inferred← citeshttps://doi.org/10.1371/journal.pone.0290739openalex-snapshot
Evaluating the potential of Vitamin D and curcumin to alleviate inflammation and mitigate the progression of osteoarthritis through their effects on human chondrocytes: A proof-of-concept investigation
inferred← citeshttps://doi.org/10.1517/13543784.2013.770837openalex-snapshot
Disease-modifying osteoarthritis drugs:in vitroandin vivodata on the development of DMOADs under investigation
inferred← citeshttps://doi.org/10.1517/14656566.2013.825606openalex-snapshot
New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?
inferred← citeshttps://doi.org/10.1517/14728214.2015.1037275openalex-snapshot
Emerging drugs for the treatment of knee osteoarthritis
inferred← citeshttps://doi.org/10.15446/rev.colomb.biote.v19n2.70276openalex-snapshot
Terapias Celulares y Productos de Ingeniería de Tejidos para el Tratamiento de Lesiones Condrales de Rodilla
inferred← citeshttps://doi.org/10.17760/d20317943openalex-snapshot
Synthesis of cartilage targeting multi-arm Avidin as a cationic drug carrier
inferred← citeshttps://doi.org/10.17760/d20416627openalex-snapshot
Development of age and injury induced osteoarthritis models for evaluation of therapeutics and their delivery systems
inferred← citeshttps://doi.org/10.17760/d20449631openalex-snapshot
Electro-diffusive transport of cationic peptide carriers in negatively charged joint environment for applications in targeted drug delivery
inferred← citeshttps://doi.org/10.18502/wkmj.v65i4.14677openalex-snapshot
New Horizons in Treatment of Knee Osteoarthritis: A Brief Look-up at Emerging Approaches
inferred← citeshttps://doi.org/10.2119/molmed.2014.00232openalex-snapshot
An Expanding Role for Interleukin-1 Blockade from Gout to Cancer
inferred← citeshttps://doi.org/10.21203/rs.3.rs-41634/v1openalex-snapshot
Blood levels of matrix metalloproteinase generated C-reactive protein metabolite (CRPM) are a sensitive measure of chronic inflammation in OA
inferred← citeshttps://doi.org/10.2147/btt.s199862openalex-snapshot
Systematic review of immunomodulatory therapies for hidradenitis suppurativa
inferred← citeshttps://doi.org/10.2147/dddt.s295224openalex-snapshot
The Development of Disease-Modifying Therapies for Osteoarthritis (DMOADs): The Evidence to Date
inferred← citeshttps://doi.org/10.2147/dmso.s520465openalex-snapshot
Is It Time to Revisit the Role of Interleukin-1 Inhibitors in Osteoarthritis?
inferred← citeshttps://doi.org/10.2147/oarrr.s176666openalex-snapshot
Novel treatments for osteoarthritis: a recent update
inferred← citeshttps://doi.org/10.2165/11599350-000000000-00000openalex-snapshot
Role of Interleukin-1 Inhibitors in Osteoarthritis
inferred← citeshttps://doi.org/10.2174/1381612821666150310144940openalex-snapshot
Biological Therapies in Osteoarthritis
inferred← citeshttps://doi.org/10.2174/1567201819666220901092832openalex-snapshot
Novel Formulation Approaches used for the Management of Osteoarthritis: A Recent Review
inferred← citeshttps://doi.org/10.2174/1573397117666211116111738openalex-snapshot
Emerging and New Treatment Options for Knee Osteoarthritis
inferred← citeshttps://doi.org/10.2174/1871527322666221226145828openalex-snapshot
Imbalance of Th1 and Th2 Cytokines and Stem Cell Therapy in Pathological Pain
inferred← citeshttps://doi.org/10.22038/abjs.2021.56530.2807openalex-snapshot
The Current Role of Disease-modifying Osteoarthritis Drugs.
inferred← citeshttps://doi.org/10.22203/ecm.v034a21openalex-snapshot
Sustained intra-cartilage delivery of low dose dexamethasone using a cationic carrier for treatment of post traumatic osteoarthritis
inferred← citeshttps://doi.org/10.3109/03009742.2015.1060259openalex-snapshot
Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?
inferred← citeshttps://doi.org/10.33540/1023openalex-snapshot
Tools and Technologies for Cartilage Repair
inferred← citeshttps://doi.org/10.33590/emj/10314447openalex-snapshot
New Drug Treatments for Osteoarthritis: What Is on the Horizon?
inferred← citeshttps://doi.org/10.3389/fcell.2021.628330openalex-snapshot
The P2X7 Receptor in Osteoarthritis
inferred← citeshttps://doi.org/10.3389/fcell.2021.718938openalex-snapshot
Pro-regenerative Dialogue Between Macrophages and Mesenchymal Stem/Stromal Cells in Osteoarthritis
showing the first 200 of 245 · page through all 245
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.